Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England) 2024;403:2100–32.
Prust ML, Forman R, Ovbiagele B. Addressing disparities in the global epidemiology of stroke. Nat Rev Neurol. 2024;20:207–21.
Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke. 2014;45:663–9.
Schulze MB. Metabolic health in normal-weight and obese individuals. Diabetologia. 2019;62:558–66.
Schulze MB, Stefan N. Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications. Nat Rev Endocrinol. 2024;20:633–46.
Li S, Sun X, Zhao Y, Wang X, Ji X, Sang S, et al. Association between metabolic syndrome and asymptomatic cerebral arterial stenosis: a cross-sectional study in Shandong, China. Front Neurol. 2021;12:644963.
Article PubMed PubMed Central Google Scholar
Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 2005;65:296–8.
Article CAS PubMed Google Scholar
Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, Boden-Albala B, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2009;28:65–71.
Article PubMed PubMed Central Google Scholar
Wang Q, Zhao Y, Wang X, Ji X, Sang S, Shao S, et al. Association between asymptomatic intracranial arterial stenosis and insulin resistance or diabetes mellitus: a cross-sectional study in rural Shandong, China. BMJ Open Diab Res Care. 2020;8:e001788.
Article PubMed PubMed Central Google Scholar
Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41:bnaa004.
Article PubMed PubMed Central Google Scholar
Horn JW, Feng T, Mørkedal B, Strand LB, Horn J, Mukamal K, et al. Obesity and risk for first ischemic stroke depends on metabolic syndrome: The HUNT study. Stroke. 2021;52:3555–61.
Article CAS PubMed Google Scholar
Mirzaei B, Abdi H, Serahati S, Barzin M, Niroomand M, Azizi F, et al. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study. Atherosclerosis. 2017;258:65–71.
Article CAS PubMed Google Scholar
Yu M, Zhang S, Wang L, Wu J, Li X, Yuan J. Metabolically healthy obesity and carotid plaque among steelworkers in North China: the role of inflammation. Nutrients. 2022;14:5123.
Article CAS PubMed PubMed Central Google Scholar
Gao M, Lv J, Yu C, Guo Y, Bian Z, Yang R, et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study. PLoS Med. 2020;17:e1003351.
Article CAS PubMed PubMed Central Google Scholar
Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. The Lancet. Diab Endocrinol. 2018;6:714–24.
Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prevent Cardiol. 2016;23:956–66.
Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diab Care. 2013;36:2294–300.
Zembic A, Eckel N, Stefan N, Baudry J, Schulze MB. An empirically derived definition of metabolically healthy obesity based on risk of cardiovascular and total mortality. JAMA Netw Open. 2021;4:e218505.
Article PubMed PubMed Central Google Scholar
Li Q, Wang P, Ma R, Guo X, Sun Y, Zhang X. A novel criterion of metabolically healthy obesity could effectively identify individuals with low cardiovascular risk among Chinese cohort. Front Endocrinol. 2023;14:1140472.
Seo DH, Cho Y, Seo S, Ahn SH, Hong S, Ha KH, et al. Association between metabolically healthy obesity and subclinical atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort. J Clin Med. 2022;11:2440.
Article CAS PubMed PubMed Central Google Scholar
Wang X, Zhao Y, Ji X, Sang S, Shao S, Yan P, et al. Kongcun town asymptomatic intracranial artery stenosis study in Shandong, China: cohort profile. BMJ Open. 2020;10:e036454.
Article PubMed PubMed Central Google Scholar
Zhao W, Ma X, Ju J, Zhao Y, Wang X, Li S, et al. Association of visceral adiposity index with asymptomatic intracranial arterial stenosis: a population-based study in Shandong, China. Lipids Health Dis. 2023;22:64.
Article PubMed PubMed Central Google Scholar
Yang W, Li JP, Zhang Y, Fan FF, Xu XP, Wang BY, et al. Association between body mass index and all-cause mortality in hypertensive adults: results from the China Stroke Primary Prevention Trial (CSPPT). Nutrients. 2016;8:384.
Article PubMed PubMed Central Google Scholar
Sun Q, Wang Q, Wang X, Ji X, Sang S, Shao S, et al. Prevalence and cardiovascular risk factors of asymptomatic intracranial arterial stenosis: the Kongcun Town Study in Shandong, China. Eur J Neurol. 2020;27:729–35.
Article CAS PubMed Google Scholar
Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. Ajnr Am J Neuroradiol. 2000;21:643–6.
CAS PubMed PubMed Central Google Scholar
Lee HJ, Choi EK, Lee SH, Kim YJ, Han KD, Oh S. Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study. PloS ONE. 2018;13:e0195210.
Article PubMed PubMed Central Google Scholar
Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97:2482–8.
Article CAS PubMed PubMed Central Google Scholar
Opio J, Croker E, Odongo GS, Attia J, Wynne K, McEvoy M. Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: A systematic review and meta-analysis of prospective cohort studies. Obes Rev. 2020;21:e13127.
Hu C, Wang S, Lin H, Wan Q, Zheng R, Zhu Y, et al. Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diab Obes Metab. 2024;26:2176–87.
Agius R, Pace NP, Fava S. Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight. Diab Metab Res Rev. 2024;40:e3725.
Goossens GH. The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts. 2017;10:207–15.
Article CAS PubMed PubMed Central Google Scholar
Martin S, Cule M, Basty N, Tyrrell J, Beaumont RN, Wood AR, et al. Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease. Diabetes. 2021;70:1843–56.
Article CAS PubMed Google Scholar
Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015;518:187–96.
留言 (0)